For the treatment of respiratory diseases, the intratracheal administration of hydrogel combined with fibroblast growth factor and interleukin-10 (IL-10) could alleviate monocutarine-induced pulmonary hypertension and bleomycin-induced pulmonary fibrosis, respectively [20, 21]. This evidence concerns the gene IL10 and pulmonary arterial hypertension.